コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 IL-17R deficiency conferred a reduction in neutrophil nu
2 IL-17R knockout (KO) mice displayed a significant delay
3 IL-17R signaling is critical for pulmonary neutrophil re
4 IL-17R(-/-) mice demonstrated systemic antimicroflora Ab
5 IL-17R(-/-) mice developed a normal adaptive immunity ag
6 IL-17R-deficient mice were exquisitely sensitive to intr
7 IL-17R:Fc (50-200 microg/ml) markedly inhibited T cell p
8 IL-17R:Fc for 6 days decreased MNC infiltration in the i
9 IL-17R:Fc or control human immunoglobulin G was administ
10 IL-17R:Fc or control IgG was added at the start of mouse
15 leukin 23 (IL-23), IL-1 receptor I (IL-1RI), IL-17R, tissue inhibitors of metalloproteinase 1 and 2 (
16 ngly dependent on the interleukin-23 (IL-23)/IL-17R axis, as mice and humans with defects in IL-17R s
17 sed by the commensal fungus Candida albicans IL-17R signaling is essential to prevent OPC in mice and
18 r signaling domain was identified within all IL-17Rs, termed similar expression to fibroblast growth
23 ial cells (IECs), miR-146a targets TRAF6, an IL-17R signaling intermediate, to restrict IEC responsiv
25 dies showing the effectiveness of IL-17- and IL-17R-blocking antibodies in alleviating psoriatic itch
27 r expression to fibroblast growth factor and IL-17R; Toll-IL-1R)-related signaling molecules, such as
29 ession to fibroblast growth factor genes and IL-17R domain and coordinates 2 separate proinflammatory
31 ession to fibroblast growth factor genes and IL-17Rs (SEFIR) domain of IL-17RC, but the SEFIR is esse
32 omeric complexes between IL-17RA and another IL-17R trigger signaling by binding the downstream trans
33 urthermore, treatment with neutralizing anti-IL-17R antibody ablated the enhanced survival observed i
34 A and IL-17F were blocked by a specific anti-IL-17R Ab, but only IL-17A was blocked with a soluble IL
36 The levels of intestinal pIgR and IgA in B6.IL-17R (IL-17R(-/-)) mice were lower than wild type mice
37 nhibited in mice that were deficient in both IL-17R and IFN-gammaR compared with wild-type animals.
39 ted that hBD-2 stimulation was attenuated by IL-17R-specific Ab, but not by IL-1R antagonist or the n
42 to the knee joint of naive IL-17R-deficient (IL-17R-/-) mice had no effect on the acute phase of arth
45 o experimental autoimmune encephalomyelitis, IL-17R-signaling-deficient mice demonstrated earlier dis
46 nship between the gut microbiota and enteric IL-17R signaling that controlled dysbiosis, constrained
47 mily adaptor MyD88, which is dispensable for IL-17R signaling, was required for ORF8 activity yet MyD
48 row (BM) chimeric mice revealed the need for IL-17R expression on radiation-resistant joint cells for
49 y cells in human lung tissue, and functional IL-17R signaling occurs on the basolateral surface of hu
56 17R axis, as mice and humans with defects in IL-17R signaling (IL17F, ACT1, IL-17RA) or in genes that
58 of IL-17 in IFN-gammaR(-/-) or IFN-gamma in IL-17R(-/-) mice further suppresses the adoptive transfe
60 creased only in IL-21R(-/-) mice, but not in IL-17R(-/-) mice, after reinfection with C. rodentium co
65 rain-region-specific expression of all major IL-17R subunits and found that in addition to IL-17RA, I
67 oluble IL-17R, suggesting that cell membrane IL-17R is required for signaling by both IL-17A and IL-1
69 wall) directly into the knee joint of naive IL-17R-deficient (IL-17R-/-) mice had no effect on the a
71 or C (IL-17RC), and adaptor protein Act1 (of IL-17R) all had reduced demyelination accompanied by les
72 an important signal transducing component of IL-17R, we established that IL-17 signaling is regulated
73 Functional studies with mice deficient of IL-17R, IL-17A, and IL-17F further revealed that IL-17 s
74 his study, by cell type-specific deletion of IL-17R and adaptor Act1, we demonstrated that IL-17R/Act
77 e to initiate normal signaling downstream of IL-17R engagement likely contributes to the patients' re
79 CH1 activation results in the interaction of IL-17R adaptor Act1 with NICD1, followed by the transloc
82 macrophages in the hapten challenged skin of IL-17R(-/-) recipients is significantly reduced whereas
90 neumoniae inoculation and that IL-23 p19-/-, IL-17R-/-, and IL-12 p35-/- mice also show increased sus
91 of MCPIP1 on IL-6, IkappaBzeta, and possibly IL-17R subunits results in a biologically relevant inhib
92 iciency in IL-23, IL-17A, or IL-17 receptor (IL-17R) and mAb neutralization of CXCR2, the p19 subunit
94 Furthermore, the levels of IL-17 receptor (IL-17R) on the TRAF6-deficient EFs were comparable to th
96 the adaptor protein Act1 in IL-17 receptor (IL-17R) signaling and IL-17-dependent immune responses.
97 Interleukin-17 (IL-17) and IL-17 receptor (IL-17R) signaling are essential for regulating mucosal h
100 itin ligase, is recruited to IL-17 receptor (IL-17R) upon IL-17 stimulation and is required for IL-17
101 m wild-type mice, those from IL-17 receptor (IL-17R)-deficient mice had significantly lower corneal p
102 F were rendered sensitive in IL-17 receptor (IL-17R)-knockout hosts deficient in T(H)17 effector func
103 le of interleukin-17 (IL-17)/IL-17 receptor (IL-17R)-mediated signaling in the protective immunity ag
104 (CXCR2) nor interleukin-17 (IL-17) receptor (IL-17R) deficiency changed the severity of disease follo
105 17 mediates inflammation through a receptor (IL-17R) composed of two subunits, IL-17RA and IL-17RC.
108 Namely, IL-17Rs contain a conserved SEF/IL-17R (SEFIR) subdomain that engages Act1, leading to a
109 We demonstrate that the intracellular Sef/IL-17R (SEFIR) domain of IL-17RD targets TIR adaptor pro
111 in IL-17RC(-/-) fibroblasts required the SEF/IL-17R signaling domain (SEFIR), a conserved motif commo
112 -23 and was critical for host defense, since IL-17R-deficient mice had a phenotype similar to that of
113 L-17D.2, IL-17E, IL-17B, and IL-17C) and six IL-17R genes (IL-17RA.1, IL-17RA.2, IL-17RA.3, IL-17RF,
114 , but only IL-17A was blocked with a soluble IL-17R, suggesting that cell membrane IL-17R is required
116 L-17R and adaptor Act1, we demonstrated that IL-17R/Act1 exerts a direct impact on the contraction of
119 Bone marrow transplantation revealed that IL-17R expression on nonhemopoietic cells had the greate
125 The signature cytokine, IL-17, engages the IL-17R and recruits the E3-ligase NF-kappaB activator 1
128 based approach to identify components of the IL-17R complex followed by analysis of their roles using
132 dy provides the first structural view of the IL-17R intracellular signaling, unraveling the mechanism
133 , and demonstrates the essential role of the IL-17R on keratinocytes in driving disease pathogenesis.
136 , recruitment of Act1 to IL-17R required the IL-17R conserved cytoplasmic 'SEFIR' domain, followed by
140 IL-17Rh1, a protein distantly related to the IL-17R, suggesting that IL-17E probably possesses unique
141 ine nucleotide exchange factor [GEF]) to the IL-17R/Act1 complex in ASMCs, resulting in activation of
142 restricted to activated T cells, whereas the IL-17R is expressed in a variety of cell types including
143 suggesting that IL-17RA subunits within the IL-17R complex undergo a conformational change upon liga
149 imulation with IL-17, recruitment of Act1 to IL-17R required the IL-17R conserved cytoplasmic 'SEFIR'
152 dentified in an EST data base by homology to IL-17R, was found to bind specifically IL-17B, as determ
153 ntraction via direct recruitment of Rab35 to IL-17R, followed by PKCalpha activation and stress fiber
155 L-17A on circulating neutrophil levels using IL-17R-deficient (Il17ra(-/-)) mice and Il17ra(-/-)Itgb2
156 gh the interactions of IL-17A or IL-17F with IL-17R was confirmed in splenocyte cultures in vitro.
158 1) is an adapter protein that interacts with IL-17R via its similar expression to fibroblast growth f